The effects of serum iron level without anemia on long-term prognosis of patients with coronary heart disease complicated with chronic heart failure: a retrospective cohort study
- 1 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Heart and Vessels
- Vol. 35 (10), 1419-1428
- https://doi.org/10.1007/s00380-020-01613-0
Abstract
The effects of serum iron level without anemia on long-term prognosis of patients with coronary heart disease (CHD) complicated with chronic heart failure (CHF) is still unclear. The objective of this study was to explore the effects of serum iron level without anemia on long-term prognosis of patients with CHD complicated with CHF. In this retrospective cohort study, 221 patients with CHD complicated with CHF were consecutively investigated. These patients were divided into three groups according to the tertiles of the serum iron level: low-iron group (n = 71), medium-iron group (n = 76) and high-iron group (n = 74). The overall serum iron without anemia was 13.0 +/- 5.50 mu mol/L and serum iron in each group was 7.58 +/- 1.63 mu mol/L, 11.94 +/- 1.79 mu mol/L, and 19.37 +/- 3.81 mu mol/L, respectively. Composite endpoint events were composed of major adverse cardiovascular and cerebrovascular events (MACCE), including recurrent heart failure, all-cause death, acute coronary syndrome (ACS) and ischemic stroke. The median follow-up duration was 239 days. After adjusting relevant confounding risk factors, we found that excessively low or high serum iron level is correlated to the MACCE in patients with CHD complicated with CHF and that the prognosis of patients with excessively high serum iron level is poorer than that of patients with excessively low serum iron level. We further revealed the effect of serum iron level on MACCE is U-shaped, but not linear relationship. Sensitivity analysis showed that the correlation between serum iron level and MACCE is stable. In addition, according to the test for interaction, the variables that modify the effect including CRP (P for interaction < 0.0001), diuretics (P for interaction = 0.0212) and antiplatelet drugs (P for interaction = 0.0167). This study showed that excessively low or high serum iron level without anemia is an independent risk factor of MACCE in patients with CHD complicating with CHF.This publication has 28 references indexed in Scilit:
- Epidemiology of Heart FailureCirculation Research, 2013
- Heme Iron Intake and Risk of StrokeStroke, 2013
- Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectivesEuropean Heart Journal, 2012
- Hepcidin Destabilizes Atherosclerotic Plaque Via Overactivating Macrophages After ErythrophagocytosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Trends in Comorbidity, Disability, and Polypharmacy in Heart FailureThe American Journal of Medicine, 2011
- Iron-Induced Cardiac Damage: Role of Apoptosis and Deferasirox InterventionThe Journal of pharmacology and experimental therapeutics, 2010
- Anemia is an Independent Predictor of Long-Term Adverse Outcomes in Patients Hospitalized With Heart Failure in Japan A Report From the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)Circulation Journal, 2009
- Clinical epidemiology of heart failureHeart, 2007
- Dietary haem iron and coronary heart disease in womenEuropean Heart Journal, 2004